We are rising to the evolving challenges of the COVID-19 pandemic.
The COVID-19 pandemic remains an unrivaled scientific and global health challenge.
Since the pandemic was first detected, MSD has been fully committed to deploying the expertise and the resources available at our disposal to help address COVID-19.
However, we also recognize that success over COVID-19 will require continued collaboration among governments, organizations, individuals, and all members of society.
Let us all work together to make COVID-19 a thing of the past.
Clinical trial sites seek participants to test molnupiravir’s potential in preventing COVID-19 among close contacts
MSD biopharmaceutical company is checking the efficacy and safety of the investigational drug molnupiravir in preventing COVID-19 infection among close contacts. A total of 1,332 participants will be recruited globally, of which 30 will come from the Philippines. MSD Philippines has partnered with Asian Hospital and Medical Center and Quirino Memorial Medical Center (QMMC) as […]